Soligenix and SciClone Establish Regional Licensing Agreement for SGX942 a Novel Product Candidate for Oral Mucositis

PRINCETON N.J. and FOSTER CITY Calif. Sept. 12 2016 PRNewswire &160;Soligenix Inc. OTCQB SNGX a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need and SciCl...